Shaverdian, N., Tenn, S., Veruttipong, D., Wang, J., Hegde, J., Lee, C., . . . Lee, P. (2016). The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy. Br J Radiol.
Citación estilo ChicagoShaverdian, Narek, et al. "The Significance of PTV Dose Coverage On Cancer Control Outcomes in Early Stage Non-small Cell Lung Cancer Patients Treated With Highly Ablative Stereotactic Body Radiation Therapy." Br J Radiol 2016.
Cita MLAShaverdian, Narek, et al. "The Significance of PTV Dose Coverage On Cancer Control Outcomes in Early Stage Non-small Cell Lung Cancer Patients Treated With Highly Ablative Stereotactic Body Radiation Therapy." Br J Radiol 2016.